Olink Holding (OLK) Financial Analysis & Valuation | Quarter Chart
Olink Holding (OLK)
OLKPrice: $26.08
Fair Value: 🔒
🔒score
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation disea... more
Olink Holding AB (publ) provides various products and services for the academic, government, biophar... more
Description
Shares
| Market Cap | $3.24B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | SE | CEO | Jon Heimer |
| IPO Date | 2021-03-26 | CAGR | 0.42% |
| Employees | 707 | Website | www.olink.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
OLK chart loading...
Fundamentals
Technicals
| Enterprise Value | $2.84B | P/E Ratio | -96.59 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 19.09 | P/B Ratio | 6.43 |
| P/CF Ratio | -107.66 | P/FCF Ratio | -63.17 |
| EPS | $-0.27 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 18.54% | Gross Margin | 0.58% |
| Operating Margin | -0.29% | Profit Margin | -0.19% |
| ROE | -0.07% | ROA | -0.05% |
| ROCE | -0.09% | Current Ratio | 4.75 |
| Quick Ratio | 3.55 | Cash Ratio | 2.18 |
| Debt/Equity | 0.05 | Interest Coverage | -58.21 |
| Altman Z Score | 24 | Piotroski Score | 1 |